Lucitanib
- Generic Name
- Lucitanib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H25N3O4
- CAS Number
- 1058137-23-7
- Unique Ingredient Identifier
- PP449XA4BH
- Background
Lucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath